Log In
Print this Print this

Nutropin AQ/Increlex injection

  Manage Alerts
Collapse Summary General Information
Company Ipsen Group
DescriptionRecombinant human insulin-like growth factor-1 (IGF-1) combined with recombinant human growth hormone (rhGH)
Molecular Target Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)
Mechanism of ActionHormone replacement therapy
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today